Anthony with Yahoo Finance

We are continuing to see a nice price/volume mix, with the candles showing underlying strength. Short sellers are about to get squeezed, big-time. Let’s face it, when the fundamentals align with the technicals, it’s a recipe for an upside explosion.
 




We are continuing to see a nice price/volume mix, with the candles showing underlying strength. Short sellers are about to get squeezed, big-time. Let’s face it, when the fundamentals align with the technicals, it’s a recipe for an upside explosion.

This company is a complete ripoff. This all about CEO and his buddies raiding the coffers. And it's people like Anthony who are being paid by Esperion to post his nonsense here and on Yahoo Finance Esperion conversation page. Total loser.
 




We are continuing to see a nice price/volume mix, with the candles showing underlying strength. Short sellers are about to get squeezed, big-time. Let’s face it, when the fundamentals align with the technicals, it’s a recipe for an upside explosion.

As the stock is down 6% today.
Keep up the good advice.
 








Anthony is hated also by posters on Yahoo finance ESPR board. He lies like crazy over there with his bombastic predictions. It's criminal on what's happened to Esperion with this management team.
 








Anthony never stops. He's so full of shit tha he has to come to this board and spew his ridiculous predictions about Esperion being worth 5 billion. Looknat the debt this company has and the terrible sales to date. Could this have gone any worse since 2020. Managed care will never buy into this regardless of data.
 




Nice to see the stock up on a day that really produced a very tough tape. Investors are looking for security and comfort in this choppy market. The consolidation around this base is looking very solid, and directionally very exciting to see. There is just a lot more positive chatter about the stock, and that always leads to good things.
 




Nice to see the stock up on a day that really produced a very tough tape. Investors are looking for security and comfort in this choppy market. The consolidation around this base is looking very solid, and directionally very exciting to see. There is just a lot more positive chatter about the stock, and that always leads to good things.

Your the only one on the planet talking this up. What about the Fundamentals? Are they aligned for a runway? Uptick? What a clown.
 




The drug is selling like crazy in Europe. Year over year growth 147 percent. Quarter over quarter growth 37.5 percent. Old management was the worst and new management is meh. But this drug is going to be a multi billion dollar drug despite management. Hockey puck forming in Europe and some big pharma is going to do that in the US. Much Larger label coming in US end of March and Dr Peter Attia with 430,000 followers roughly loves the drug. The main issue is getting payers to change and that will come by the summer.
 




Your the only one on the planet talking this up. What about the Fundamentals? Are they aligned for a runway? Uptick? What a clown.
European sales are getting so huge someone is just going to take them out. It is almost DSE's fastest selling drug and will be officially next quarter. I don't care if espr can't sell water in the desert. Someone else can and they will be bought. Dr Peter Attia always raves about this drug and his following is massive at roughly 430,000 and rapidly growing.
 




We are continuing to see a nice price/volume mix, with the candles showing underlying strength. Short sellers are about to get squeezed, big-time. Let’s face it, when the fundamentals align with the technicals, it’s a recipe for an upside explosion.

People took notice of DSE's sales growth that story will be a massive one by end of the year and short term big pharma is starting to notice this a multi billion dollar a year drug in the right hands. DSE is the right hands for Europe and maybe the US too. But if not them someone else going to take them out come summer time. How well Espr can sell it on their own will justify higher or lower price on buyout.
 




The drug is selling like crazy in Europe. Year over year growth 147 percent. Quarter over quarter growth 37.5 percent. Old management was the worst and new management is meh. But this drug is going to be a multi billion dollar drug despite management. Hockey puck forming in Europe and some big pharma is going to do that in the US. Much Larger label coming in US end of March and Dr Peter Attia with 430,000 followers roughly loves the drug. The main issue is getting payers to change and that will come by the summer.

Anthony your such a fool. We can't help that your friends are coming over from Yahoo Finance board to see what a jackass your making of yourself talking this company up like they cured cancer. And for the love of Christ this isn't a European healthcare system here in the states. Who cares what is going on in Europe. Those countries are paying entirely for BA. No matter how good the drug is and efficacy off the chart managed care holds all the cards. And doctor offices hate prior authorizations with their cumbersome extensive 10 page forms. Offices are busy and doctors and office managers don't want to spend their days filling out extensive paperwork when they could be helping with patients. If you ever had spent a few days in field sales you would know this. Your totally detached from pharma reality. And Europe is a completely different socialized market. You need a hobby!
 




European sales are getting so huge someone is just going to take them out. It is almost DSE's fastest selling drug and will be officially next quarter. I don't care if espr can't sell water in the desert. Someone else can and they will be bought. Dr Peter Attia always raves about this drug and his following is massive at roughly 430,000 and rapidly growing.
Atai and Nissen are both major KOL supporters that are driving significant awareness and overall acceptance. Nice to have this support!
 












The numbers don’t lie you can’t deny the trend. Clearly things are moving up and we are poised for yet another uptick. The optics around the rationale for a move are clear. Very much looking forward to that next earnings report, and the guidance that will be provided for the remainder of the year. Short, you’ve been warned.
 




The numbers don’t lie you can’t deny the trend. Clearly things are moving up and we are poised for yet another uptick. The optics around the rationale for a move are clear. Very much looking forward to that next earnings report, and the guidance that will be provided for the remainder of the year. Short, you’ve been warned.

Fuck off Anthony you hack. Go back and spout your dribble to your pals at Yahoo Finance ESPR board. Amazing how you and your pals spend so much time on this Mickey Mouse company.
 




Anthony I invite you come spend a day in the field with me so this way you can see firsthand what my doctors and staff thi k of BA. Maybe some of your over the top comments will grow my business. They would love for you to explain the insurance hurdles we experience in the field. Pick a place in the country you want to spend a day in the field with and will make it happen.